Resalis Therapeutics is founded in 2021, operates from its headquarter in Via Nizza, 52 Turin, Piedmont 10126, IT. The company operates in the Hospitals & Healthcare, Medical Practices sector.
Resalis Therapeutics specializes in Metabolic disease approach, Non-coding RNA drug modality, Lipid metabolism, Clinical trial development, and offers services including RES-010 treatment, Disease-modifying therapeutic impact, and Durable weight loss.